Abstract: A case of a female patient with thalidomide-induced phocomelia and additional dermal complications associated with the prosthesis itself is presented herein.
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Letter to the Editor
Thalidomide-induced phocomelia is considered the biggest pharmacological disaster in medical history [1] [2] [3] [4] . It was originally designed and marketed as a sedative and anti-hypnotic drug in the late 1950's and was also used for morning sickness relief during early pregnancy [1] [2] [3] [4] . Unfortunately, a few years after the official drug release, an epidemic of birth deformities arose that is estimated to have affected more than 10.000 children worldwide. Besides limb defects, thalidomide was also found to be responsible for ear and eye problems, genital abnormalities, peripheral neuropathies and kidney, lung, intestinal tract and heart problems [1] [2] [3] [4] [5] . The true incidence of thalidomide-induced defects still remains obscure because the drug was prescribed even after it was verified to be the reason for the aforementioned epidemic outbreak [1] [2] [3] [4] [5] .We report a case of a female patient with thalidomide-induced phocomelia and additional dermal complications associated with the prosthesis itself.
A 40-year-old white Caucasian woman presented to the orthopaedics department for evaluation of a lower limb prosthesis. The patient reported mild pain and skin irritation of the residual limb. Medical history revealed that her mother was prescribed thalidomide as an antiemetic drug during pregnancy and that the patient was born with upper and lower limb defects ( Figure  1 ). The limb malformations involved both upper limbs (upper limb phocomelia) and the right lower limb (below the knee "amputation"). The patient reported the use of different prosthetic devices for the past decades to (Figure 2 ). Skin rashes, blisters, and ingrown hairs were depicted, and the patient was referred to a specialized orthopaedic center for possible replacement of her prosthetic lower limb.
Recent advances in molecular biology and biochemistry have resulted in the development of new thalidomide derivatives and analogues that are currently being used in a number of diseases [1] [2] [3] [4] [5] [6] . Thalidomide has been shown to be effective in the treatment of AIDS, cancer and Crohn disease and is currently in clinical use as a therapeutic option for multiple myeloma and leprosy under strict guidelines [1] [2] [3] [4] [5] [6] . Even nowadays, however, there are reports of children being born with thalidomide-induced limb defects in underdeveloped countries, where the drug is the preferred treatment for leprosy [1] [2] [3] [4] [5] [6] . In our case, the patient reported maternal use of the drug during pregnancy nearly ten years after the official ban in 1962. This fact strengthens the issue mentioned above that the true incidence of thalidomideinduced birth defects cannot be estimated. The second point that was interesting in our case was the identification of possible dermal complications that can be faced by a patient with a lower limb prosthesis. Despite advances in technology and design, a number of problems have been seen to occur with use of prosthetic limbs [7] [8] . The most important factor is the way the prosthesis fits with the residual limb. In addition, the health of the residual limb influences the functional outcome and is of paramount importance to avoid the development of blisters, sores, and rashes [7] [8] . However it has been shown that controlling skin irritations is a difficult task, both for the patient and the treating physician. Changes in body weight, excessive perspiration, increase in warmth and moisture within the prosthesis socket occurring in warm environments; physiological age-related skin changes and possible allergic reactions to rubber or silicone are the main contributing factors to dermatological problems [7] [8] . Future advances in medicine and technology may eliminate the aforementioned issues and improve the quality of life of these patients. shows the dermal complications that are associated with her chronic use of the prosthetic device. Note skin rash, blisters, and ingrown hairs in the residual limb.
